National Advisory Council Agenda

139th Meeting of the National Advisory Council on Drug Abuse

Virtual Meeting – September 15, 2021

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2). 

11 a.m – 12:15 a.m

Time Presentation
11:00 a.m. Call to Order
Nora Volkow, M.D.
Director, NIDA

Review of Policy and Procedures
Susan Weiss, Ph.D.
Executive Secretary
National Advisory Council on Drug Abuse
Director, Division of Extramural Research, NIDA
11:15 a.m.

Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Division of Neuroscience and Behavior (DNB)
Rita Valentino, Ph.D., Director

Office of Research Training, Diversity, and Disparities (ORTDD)
Albert Avilla, Ph.D., Deputy Director

Division of Epidemiology, Services, and Prevention Research (DESPR)
Carlos Blanco, M.D., Ph.D., Director

Office of Translational Initiatives and Program Innovationa (OTIPI)
Elena Koustova, Ph.D., M.B.A., Director

Division of Therapeutics and Medical Consequences (DTMC)
Iván Montoya, Ph.D., Acting Director
12:15 p.m. Brief Break

Videocast:

Members of the public who may wish to express views regarding any items discussed during this meeting may do so by writing Dr. Troy Zarcone, within ten days of the meeting.  Any written statements by members of the public will receive careful consideration.

https://videocast.nih.gov/watch=42574

Open Session

12:45 - 4:45 p.m.

Time Presentation
12:45 p.m. Welcome and Opening Remarks
Nora Volkow, M.D., Director, NIDA
1:00 p.m. Director's Report
Nora Volkow, M.D., Director, NIDA
1:50 p.m. Discussion
Council Members
2:15 p.m. NIDA AIDS Research Program Name Change
Redonna Chandler, Ph.D., Director, NIDA AIDS Research Program
2:30 p.m. Break
Council Members
2:40 p.m. Updates from the Center for Clinical Trials Network
Betty Tai, Ph.D., Director, CCTN
3:20 p.m. NIDA Data Science: Where We Are and Where We're Going
Susan Wright, Ph.D., Health Scientist Administrator
4:00 p.m. Concept Clearances​
  • Division of Epidemiology, Services, and Prevention Research (DESPR)
    • Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Minority Populations – Sheba Dunston, Ed.D., MPH, CHES Social Behavioral Scientist Administrator, Epidemiology Research Branch
    • Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery – Carrie Mulford, Ph.D., Health Science Administrator, Services Research Branch
    • Registry of Medical Cannabis Use and Health Outcomes – Heather Kimmel, Ph.D., Health Science Administrator, Epidemiology Research Branch
    • Research Adoption Project – Tisha Wiley, Ph.D., Chief, Services Research Branch Division of Neuroscience and Behavior (DNB)
    • Actionable Data to Inform Research-Driven Decisions (HEAL Initiative Data2Action)– Tisha Wiley, Ph.D., Chief, Services Research Branch Division of Neuroscience and Behavior (DNB)
    • Real-World Data to Address Urgent OUD/SUD Needs – Tisha Wiley, Ph.D., Chief, Services Research Branch Division of Neuroscience and Behavior (DNB)
  • Division of Neuroscience and Behavior (DNB)
    • Sequencing Resource for Molecular Genetics and Epigenetics of Addiction – Jonathan Pollock, Ph.D. Chief, Genetics, Epigenetics, and Developmental Neuroscience Branch
    • NIDA Center for Genetic Studies – Jonathan Pollock, Ph.D. Chief, Genetics, Epigenetics, and Developmental Neuroscience Branch
    • Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders – Jonathan Pollock, Ph.D. Chief, Genetics, Epigenetics, and Developmental Neuroscience Branch
    • Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders – John Satterlee, Ph.D. Health Scientist Administrator 
    • Avenir Award for Chemistry and Pharmacology of Substance Use Disorders – Sam Ananthan, Ph.D. Chief, Chemistry and Pharmacology Branch 
    • Workshops on Computational and Analytical Research Methods – Vani Pariyadath, Ph.D. Chief, Behavioral and Cognitive Neuroscience Branch
  • Division of Therapeutics and Medical Consequences (DTMC)
    • NIDA Research Center of Excellence Grant Program – Kevin Walton, Ph.D. Chief, Clinical Research Grants Branch
    • Medications Development for Opioid Use Disorder (OUD) and Opioid Overdose (OOD) Expansion – Ivan Montoya, M.D., M.P.H., Acting Director, DTMC
  • Office of Translational Initiatives and Program Innovations (OTIPI)
    • Developing regulated therapeutic and diagnostic solutions for patients affected by Opioid and/or Stimulants Use Disorders (OUD/StUD) – Leonardo Angelone, Ph.D., Deputy Director, OTIPI
4:30 p.m. Public Comments
4:45 p.m. Adjourn